Mortgage Blog How a potential $1.2 billion cancer drug deal helps this East Bay biotech target diseases of aging firststargroup July 6, 2022 The deal is the third over the past year by the team behind Teneobio.
The deal is the third over the past year by the team behind Teneobio.
